Navigation Links
SPEX SkinSkan Spectro-Fluorometer

ProductsSPEX SkinSkan Spectro-Fluorometer
Company Horiba Group
Item SPEX SkinSkan Spectro-Fluorometer
Features 
  • High sensitivity
  • In vivo sampling
  • Fast wavelength scanning
  • Excellent repeatability
  • Quartz fibre bundle
  • No need for sample preparation, cuvettes, or adaptation
  • Spectrometer isolates the fluorescence signal from strong scattered backgrounds
  • Compact and transportable
  • Easy to use DataMax software
  • 125 Watt Xenon Arc light
Description The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence applications.
Info 

Related medicine products :

1. Total Internal Reflection Fluorescence Microscopy
2. Epi-Fluorescence Module
3. M Bio Fluorescence Microscope
4. TIRF (Total Internal Reflection Fluorescence)
5. FLx800 Microplate Fluorescence Reader
6. DNA Engine Opticon Continuous Fluorescence Detection System
7. DNA Engine Opticon 2 Continuous Fluorescence Detection System
8. Cargille Microscope Immersion Oils - Fluorescence Microscopy Immersion Oils
9. Factor V Leiden by PCR & Fluorescence Monitoring
10. Fluorescence Polarization (Fetal Lung Maturity)
11. HLA-B27 by PCR & Fluorescence Monitoring
Delicate # 4
Curved shafts with fine pointed tips. Smooth handle with dull finish.
Straight tips with delicate serrations. Serrated handle with polished finish.
Delicate lightly curved tips, 1 x 2 mouse style teeth. Serrated handle with polished finish.
Medicine Products:
(Date:12/2/2008)...rsity, The Brigham and Women,s Hospital (Boston), ...as found a new drug with the potential to alleviat.... , Dr Shantha Rajaratnam from Monash Universit...ical Medicine said tasimelteon, a drug which acts ...ghly effective treatment for circadian rhythm slee...
(Date:12/2/2008)...Reminder, the nation,s leading,comprehensive pati...industry,technology today at Javits Center in New...g and distributing video testimonials can be used ...popular platforms such as YouTube, Google,Videos ...ith an effective,business strategy for increasing...
(Date:12/2/2008)...enterprise software and online services veteran is...cribers of Yugma,s instant web conferencing soluti...WEB) December 2, 2008 -- Yugma , the leading web ...collaborate instantly using the Internet, announce...tive Officer. , , ,Vas has more than 20 years of e...
(Date:12/2/2008)...ecific Gamma Imaging (BSGI) has,been proven to be...nosis of,invasive lobular carcinoma (ILC), a diff...lar breast imaging technique that can see lesions ...arly stage cancers. When compared to,mammography,...BSGI has the,greatest sensitivity for detecting I...
Breaking Medicine News(10 mins):Health News:New medication brings hope of jet lag cure 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2
...preclinical trail, that siRNA packed as a tiny sph... the University of Texas M. D. Anderson Cancer Cen...nical Cancer Research, that siRNA that are wrapped... into ovarian cancer tumour cells, which could the...
...Autism could affect the entire brain, not just the...r, and reasoning it had been once thought.// A ne... in Autism (CPEA) has shown that autism affects a ... perception, movement and memory. The researchers ...
...d that Thailand’s Public Health Ministry will enco...y to help screen patients in an attempt// to preve...h Minister Pinij Charusombat said, the blue-collar...ies instead of visiting doctors, may be left out f...
...nternational AIDS Conference in Toronto have warne... plunging into a silent epidemic of AIDS//. Only 0...rth Africa carry the virus that causes AIDS. The ...of HIV infection in the world according to UNAIDS ...
Other Medicine News:Health News:Tiny Sphere Of Nanoparticles Can Fight Cancer 2Health News:Tiny Sphere Of Nanoparticles Can Fight Cancer 3Health News:Effects Of Autism On Brain Much Wider Than Presumed 2Health News:Risk of Silent AIDS epidemic in Middle East and North Africa 2
(Date:12/1/2008)...ewswire-FirstCall/ -- Genaera Corporation (Nasdaq... has begun in study MSI-1436C-102 (Study 102), the...uemine (MSI-1436) in overweight and obese type 2 d...treatment of type 2 diabetes and obesity which wor...and leptin pathways through the highly selective i...
(Date:12/1/2008)...tCall/ -- Vical Incorporated (Nasdaq: VICL ) ann...ne payment from Merck & Co., Inc. based on Mer...l of an investigational plasmid DNA (pDNA) cancer ... DNA gene delivery technology and encodes human te...he subject of separate license agreement. , ,...
(Date:11/28/2008)...FirstCall/ -- Eli Lilly and Company,(NYSE: LLY ...ion (sNDA) from,the U.S. Food and Drug Administra...he management of chronic pain. Lilly plans to resu...dding data from a recently completed positive stud... The decision does not affect duloxetine,s FD...
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-First...SF) announced today that it has received full appr...DA) for its U.S. pivotal trial to study the effect...d associated therapy in the prevention of Contrast...o approved PLC,s request to expand their investiga...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Vigorous activity protects against breast cancer 28359 1Vigorous activity protects against breast cancer 28359 2The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 1The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 2The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 3The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 4The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 5The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 6The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 7The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 8The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 9Heavy Metals Can Taint Wine 28355 1Heavy Metals Can Taint Wine 28355 2Heavy Metals Can Taint Wine 28355 3Schering Plough to Appeal Jury Decision in Missouri Reimbursement Case 28353 1Schering Plough to Appeal Jury Decision in Missouri Reimbursement Case 28353 2
...re/ -- Mersana, a,cancer therapeutics company, ann...ith its lead product candidate, XMT-1001, will,be ...g of the,American Association of Cancer Research (...A. Full text of the abstracts can be,viewed online...http://www.aacr.org/">http://www.AACR.org . , The ...
...risk of cancer,returning after surgery for Kit-pos...atients receiving placebo in this trial will now b... planned for use of Glivec as,adjuvant therapy in ...tumor , * Glivec already approved as effective the...erable Kit-positive GIST , BASEL, Switzerland, Apr...
Other Medicine Technology:Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 2Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 3Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 4Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 5Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 6